Mechanisms and Management of Inflammation-driven Cardiovascular Risk: from Obesity and Diabetes to Autoimmunity and Cancer

  • 2,479

    Total downloads

  • 10k

    Total views and downloads

Participate in this topic

Submit your idea

You will be redirected to our submission process.

Submit your manuscript summarySubmit your manuscript

Articles

CLINICAL TRIAL

Published on 21 Feb 2024

Safety and possible anti-inflammatory effect of paclitaxel associated with LDL-like nanoparticles (LDE) in patients with chronic coronary artery disease: a double-blind, placebo-controlled pilot study

  • Lucas Lage Marinho
  • Fabiana Hanna Rached
  • Aleksandra Tiemi Morikawa
  • Thauany Martins Tavoni
  • Ana Paula Toniello Cardoso
  • Roberto Vitor Almeida Torres
  • Antonildes Nascimento Assuncao
  • Carlos Vicente Serrano
  • Cesar Higa Nomura
  • Raul Cavalcante Maranhão
Safety and possible anti-inflammatory effect of paclitaxel associated with LDL-like nanoparticles (LDE) in patients with chronic coronary artery disease: a double-blind, placebo-controlled pilot study
doi 10.3389/fcvm.2024.1342832
  • 1,656 views

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Submit your idea

You will be redirected to our submission process.

Submit your manuscript summarySubmit your manuscript

Impact

  • 10kTopic views
  • 6,949Article views
  • 2,479Article downloads
View impact